Stocks Comparison
Bioceres Crop Solutions vs Scotts Miracle-Gro: revenue, profit, margins and growth compared
Bioceres Crop Solutions brought in $335.1M of revenue in fiscal 2025, Scotts Miracle-Gro $3.4B in fiscal 2025. Revenue changed by -27.9% at Bioceres Crop Solutions and -3.9% at Scotts Miracle-Gro on the year before, so Scotts Miracle-Gro grew faster. Bioceres Crop Solutions kept -16.5% of its revenue as net profit, Scotts Miracle-Gro 4.3%. Free cash flow was $44.3M at Bioceres Crop Solutions and $273.9M at Scotts Miracle-Gro.
Side by side, latest fiscal year
| BIOX | SMG | |
|---|---|---|
| Fiscal year ended | FY2025 (June 30, 2025) | FY2025 (September 30, 2025) |
| Revenue | $335.1M | $3.4B |
| Revenue growth | -27.9% | -3.9% |
| Net income | -$55.4M | $145.2M |
| Net margin | -16.5% | 4.3% |
| Free cash flow | $44.3M | $273.9M |
| Free cash flow margin | 13.2% | 8.0% |
| Earnings per share (diluted) | -$0.88 | $2.47 |
| Cash | $32.7M | $32.8M |
| Debt | n/a | $2.1B |
| Price to earnings | n/a | 20.6 |
| Market value | $23.7M | $3B |
| Dividend yield | n/a | 5.19% |
| Rank by revenue in sector | #347 of 518 · Industrials | #165 of 518 · Industrials |
Over the years
Questions about Bioceres Crop Solutions and Scotts Miracle-Gro
Which is bigger by revenue, Bioceres Crop Solutions or Scotts Miracle-Gro?
Scotts Miracle-Gro is bigger by revenue: $3.4B in fiscal 2025, against $335.1M for Bioceres Crop Solutions in fiscal 2025.
Which keeps more of its revenue as profit, Bioceres Crop Solutions or Scotts Miracle-Gro?
Bioceres Crop Solutions had a net margin of -16.5% in fiscal 2025; Scotts Miracle-Gro had 4.3% in fiscal 2025.
Which grew revenue faster, Bioceres Crop Solutions or Scotts Miracle-Gro?
In their latest fiscal years revenue changed by -27.9% at Bioceres Crop Solutions and -3.9% at Scotts Miracle-Gro.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.